TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Prof. TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Special Professor, juntendo, Japan

Dr. Toshifumi Ohkusa is a highly regarded expert in gastroenterology and microbiota research, with a distinguished career spanning over four decades. He is currently a Special Professor at the Department of Microbiota Research at Juntendo University Graduate School of Medicine. Dr. Ohkusa has made significant contributions to the field of gastroenterology, particularly in understanding ulcerative colitis and intestinal microflora. πŸŒŸπŸ‘¨β€βš•οΈ

Publication profile

Scopus

 

Education

Dr. Ohkusa completed his medical degree (M.D.) from Tokyo Medical and Dental University in 1978. He pursued a Ph.D. from the same institution, where his groundbreaking research on ulcerative colitis in hamsters through dextran sulfate sodium and changes in intestinal microflora earned him a doctorate in 1986. πŸŽ“πŸ“š

Experience

With an impressive academic journey, Dr. Ohkusa served as a Research Associate and Instructor at Tokyo Medical and Dental University from 1986 to 2001. He later joined Juntendo University, where he advanced from Assistant Professor to Associate Professor in the Department of Gastroenterology. Between 2008 and 2017, he held the prestigious position of Professor at The Jikei University Kashiwa Hospital. Currently, he leads microbiota research at Juntendo University. πŸ’ΌπŸ”¬

Research Focus

Dr. Ohkusa’s research focuses on gastroenterology, particularly the mechanisms of ulcerative colitis and the role of intestinal microflora in gastrointestinal diseases. His work on microbiota research has significantly advanced the understanding of gastrointestinal health. πŸ”¬πŸ§«

Awards and Honors

Dr. Ohkusa has received numerous accolades for his groundbreaking work in gastroenterology and internal medicine, earning recognition from both Japanese and international medical societies. πŸ†πŸŒ

Publication Top Notes

Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis (BMC Gastroenterology, (2022), 22, 1, (390), 10.1186/s12876-022-02474-9)

Vikram Kumar | Microbiology | Best Research Article Award

Dr. Vikram Kumar | Microbiology | Best Research Article Award

Assistant professor, SRM University Delhi-NCR Sonepat Haryana, India

Profile

Google Scholar

Short Bio πŸ§‘β€πŸ”¬

Dr. Vikram is a dedicated microbiologist with a Ph.D. from NIFTEM-K, Sonepat. His research primarily focuses on riboflavin-producing probiotic strains and their applications in food safety and health. With a robust academic foundation and extensive publication record, Dr. Vikram aims to advance the fields of microbiology and biotechnology through innovative research and collaborative efforts.

Education πŸŽ“

Dr. Vikram completed his Ph.D. in Microbiology from NIFTEM-K, Sonepat, in 2024, achieving a CGPA of 6.7. He holds an M.Sc. in Microbiology from Maharshi Dayanand University, Rohtak, where he earned 7.89. Prior to that, he obtained a B.Sc. in Microbiology from the University of Delhi with a percentage of 67%. His academic journey laid a strong foundation for his research in microbial technology and applications.

Experience πŸ’Ό

Dr. Vikram has served as a mentor for two M.Tech. students, guiding their projects on encapsulation techniques and probiotic development. His hands-on experience with microbiological and molecular techniques equips him with the skills necessary for impactful research. Dr. Vikram’s commitment to teaching and mentorship highlights his dedication to fostering the next generation of scientists in the field of microbiology.

Research Interests πŸ”¬

Dr. Vikram’s research interests include microbiological techniques, probiotic development, and the applications of riboflavin-producing strains in food technology. He is particularly passionate about exploring the potential of probiotics in enhancing food safety and health benefits through innovative biotechnological solutions.

Awards πŸ†

Dr. Vikram has been recognized for his academic excellence and research contributions. His work has been pivotal in advancing knowledge in the field of microbiology, and he continues to strive for innovation and improvement in his research methodologies. He aims to further his impact by receiving the “Best Scholar Award,” which would recognize his dedication and achievements.

Publications Top Notes πŸ“š

Dr. Vikram has authored and co-authored numerous publications in reputable journals. Here are some notable works:

  1. Kumar, V., Mishra, V., Rana, A., Ahire, J.J. (2022). Riboswitch-mediated regulation of riboflavin biosynthesis genes in prokaryotes. 3 Biotech. https://doi.org/10.1007/s13205-022-03348-3
    Cited by 45 articles
  2. Kumar, V., Ahire, J.J., Taneja, N.K. (2023). Techno-Functional Assessment of Riboflavin-Enriched Yogurt-Based Fermented Milk Prepared by Supplementing Riboflavin-Producing Probiotic Strains of Lactiplantibacillus plantarum. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-022-1026-6
    Cited by 10 articles
  3. Kumar, V., Taneja, N.K., Ahire, J.J. (2023). Microencapsulation of riboflavin-producing Lactiplantibacillus plantarum MTCC 25432 and Evaluation of its Survival in Simulated Gastric and Intestinal Fluid. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10115-0
    Cited by 5 articles
  4. Kumar, V., Taneja, N.K., Ahire, J.J. (2024). Advancing microbial food safety and hazard analysis through predictive mathematical modeling. The Microbe. https://doi.org/10.1016/j.microb.2024.100049
    Cited by 2 articles
  5. Ahire, J.J., Kumar, V., & Rohilla, A. (2023). Understanding Osteoporosis: Human Bone Density, Genetic Mechanisms, Gut Microbiota, and Future Prospects. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10185-0
    Cited by 3 articles

Wael El-Sayed | Microbiology | Best Research Article Award

Prof Dr. Wael El-Sayed | Microbiology | Best Research Article Award

Professor, Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Toxicology and Physiology with over 30 years of experience in research, education, and mentorship. He has made significant contributions to the fields of toxicology, drug development, and molecular biology, particularly in understanding the therapeutic mechanisms of natural products. His academic journey has taken him from Cairo to Salt Lake City, and his work continues to impact the global scientific community.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. El-Sayed has over 30 years of experience in physiology, toxicology, drug development, molecular biology, natural products, and tissue culture research. This extensive background demonstrates his deep knowledge and expertise in these fields.
  2. Diverse Research Interests:
    • His research spans a wide range of topics, including natural products, drug-drug interactions, chemoprotection strategies in cancer, antioxidants, and biochemical and molecular toxicology. This diversity reflects his ability to contribute to various research areas, which can be a significant advantage for a “Best Research Article Award.”
  3. High-Impact Publications:
    • Dr. El-Sayed has published research in reputable journals, such as Frontiers in Oncology and Journal of King Saud University – Science, which indicates the quality and relevance of his work. His recent studies on topics like the miRNome of hepatocellular carcinoma and potential COVID-19 inhibitors showcase his involvement in cutting-edge research.
  4. International Collaboration:
    • He has collaborated with researchers from different countries and institutions, including the University of Utah, USA, and King Faisal University, Saudi Arabia. This international exposure enriches his research perspectives and broadens the impact of his work.
  5. Recent and Relevant Publications:
    • The publication dates of his work, particularly in 2022 and 2023, indicate that Dr. El-Sayed is actively engaged in current research, which is crucial for winning an award for the best research article.

Areas for Improvement

  1. Focus on Breakthrough Research:
    • While Dr. El-Sayed’s research is diverse and impactful, the award committee might prioritize groundbreaking or highly innovative work. Emphasizing and furthering research that introduces novel concepts or significantly advances existing knowledge could strengthen his candidacy.
  2. Citation Impact and Recognition:
    • Although Dr. El-Sayed has published in high-quality journals, the impact of these publications, such as citation counts or recognition in the scientific community, could be further highlighted. Demonstrating the influence of his work on the field would reinforce his qualifications for the award.
  3. Enhanced Dissemination:
    • To increase the visibility and impact of his research, Dr. El-Sayed could focus on disseminating his findings through conferences, workshops, and broader media, enhancing the accessibility and application of his work beyond academic circles.

Education πŸŽ“

Dr. El-Sayed earned his Ph.D. in Toxicology from Ain Shams University, Egypt, in collaboration with the College of Pharmacy, University of Utah, USA. His doctoral research focused on the “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats.” Prior to this, he completed his M.Sc. in Physiology from Ain Shams University, where he explored the “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats.” He also holds a B.Sc. in Science from Ain Shams University.

Experience πŸ§ͺ

Dr. El-Sayed has held several key academic positions throughout his career. Since 2014, he has been a Professor at the Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt. He previously served as an Associate Professor at the same department (2009-2014) and at the Biology Department, King Faisal University, Saudi Arabia (2007-2013). His early academic career includes his role as an Assistant Professor at Ain Shams University (2003-2009).

Research Interests πŸ”¬

Dr. El-Sayed’s research spans a broad spectrum of scientific domains, including:

  • Natural products: Investigating therapeutic properties from plant and animal sources.
  • Drug-drug interactions: Understanding how drugs interact and their metabolic pathways.
  • Novel drug evaluation: Assessing the efficacy and safety of new pharmaceuticals.
  • Cancer chemoprotection: Developing strategies for cancer prevention and treatment.
  • Antioxidants: Exploring their role in health and disease.
  • Molecular toxicology: Studying the biochemical and molecular effects of toxins.

Awards πŸ†

Dr. El-Sayed’s dedication to scientific research and education has earned him recognition in the academic community. His innovative work in toxicology and natural products has positioned him as a leader in his field, contributing to numerous advancements that have been acknowledged by peers and institutions worldwide.

Publications Top Notes πŸ“š

Dr. El-Sayed has authored numerous impactful publications. Some of his recent notable works include:

miRNome of Child A hepatocellular carcinoma in Egyptian patientsFrontiers in Oncology, 2023. DOI: 10.3389/fonc.2023.1137585
Cited by multiple studies exploring hepatocellular carcinoma.

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1H)-one, a natural product as a potential inhibitor of COVID-19Journal of King Saud University – Science, 2023. DOI: 10.1016/j.jksus.2023.102628
Referenced in research on antiviral drug development.

Investigating the Antifertility Efficacy of Testosterone on Male and Female Albino MicePakistan Journal of Zoology, 2023. DOI: 10.17582/journal.pjz/20211107091104
Contributed to studies on reproductive health.

New Benzochromeno[2,3-d]pyrimidines and Benzochromenotriazolo[1,5-c]pyrimidines as Potential Inhibitors of Topoisomerase IIPolycyclic Aromatic Compounds, 2022. DOI: 10.1080/10406638.2021.2006247
Cited in cancer research for topoisomerase inhibitors.

Conclusion

Dr. Wael M. El-Sayed is a highly qualified candidate for the “Best Research Article Award,” given his extensive experience, diverse research interests, and recent high-impact publications. His work contributes significantly to the fields of toxicology, drug development, and natural products, making him a strong contender. However, to maximize his chances, he may benefit from emphasizing the novelty and broader impact of his research, as well as enhancing its visibility within the scientific community. Overall, his credentials and contributions align well with the criteria for the award, making him a suitable candidate.